Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
Abstract This study was conducted to assess whether levetiracetam (LEV) affects the survival of patients with glioblastoma (GBM) treated with concurrent temozolomide (TMZ) chemotherapy. To this end, from 2004 to 2016, 322 patients with surgically resected and pathologically confirmed isocitrate dehy...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/c2151e0ede9f40f5bc078c0b974e815f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|